Bessemer Group’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$66.2M Sell
1,906,578
-3,741,918
-66% -$137M 0.09% 192
2026
Q2
$223M Buy
5,648,496
+2,144,490
+61% +$86.4M 0.31% 71
2026
Q1
$156M Buy
3,504,006
+3,495,136
+39,404% +$154M 0.25% 99
2025
Q4
$373K Buy
+8,870
New +$375K ﹤0.01% 1219

Other funds holding MDLN

Bessemer Group's MDLN Position: Q3 2026 in Review

Bessemer Group reduced its Medline Inc (MDLN) stake by 66% in Q3 2026, selling an estimated $137M and leaving 1,906,578 shares worth $66.2M. The position accounts for 0.09% of the portfolio, ranked #192.

Bessemer Group first reported a position in MDLN in Q4 2025 and has held it in 4 quarters since. The position peaked at $223M in Q2 2026. 261 funds tracked by Wall St. Rank hold MDLN as of Q3 2026.

  • Bessemer Group held 1,906,578 shares of Medline Inc worth $66.2M as of Q3 2026.
  • Bessemer Group sold 3,741,918 Medline Inc shares in Q3 2026, an estimated $137M.
  • Medline Inc made up 0.09% of Bessemer Group's portfolio in Q3 2026, its #192 holding.
  • Bessemer Group first reported a position in Medline Inc in Q4 2025 and has held it in 4 quarters since.
  • Bessemer Group's Medline Inc position peaked at $223M in Q2 2026.
  • 261 funds tracked by Wall St. Rank held Medline Inc as of Q3 2026.

Based on Bessemer Group's 13F filing for Q3 2026, filed 9 Nov 2026.